Clinical and statistical considerations in personalized medicine / edited by Claudio Carini, Sandeep Menon, Mark Chang. -- Boca Raton : CRC Press/Taylor & Francis, 2014. – (63.4/C641) |
Contents
Preface
Editors
Contributors
1.
Biomarkers for Drug Development: The Time Is Now!
2. RNAi
Screens: Triumphs and Tribulations
3.
Current Advances in Epigenetics
4.
Biomarkers and Precision Medicine: The Case of Rare Diseases
5.
Biomarker-Informed Adaptive Design
6.
Fitting the Dose: Adaptive Staggered Dose Design
7.
Evidence-Based Adaptive Statistical Decision and Design Strategies for
Maximizing the Efficiency of Clinical Oncology Development Programs with
Predictive Biomarkers
8.
Biomarker Identification in Clinical Trials
9.
Multiplicity in Pharmacogenomics
10.
Patient-Reported Outcomes in Personalized Medicine
11.
Regulatory Issues in Use of Biomarkers in Drug Development
Index